When is D5 (5% Dextrose) Indicated?
D5 solutions are primarily indicated as maintenance intravenous fluids in children and adults who require glucose supplementation to prevent hypoglycemia and provide caloric support, and should be combined with isotonic saline (D5 0.9% NaCl) rather than hypotonic solutions to prevent iatrogenic hyponatremia.
Primary Indications
Maintenance IV Fluids in Children
The most evidence-based indication for D5 is as part of isotonic maintenance fluids in hospitalized children aged 28 days to 18 years. The 2018 Pediatrics guideline strongly recommends D5 0.9% NaCl (5% dextrose in normal saline) over hypotonic alternatives like D5 0.45% NaCl 1. This recommendation stems from:
- Prevention of hospital-acquired hyponatremia: Hypotonic fluids cause hyponatremia in 15-30% of hospitalized patients, which can lead to fatal hyponatremic encephalopathy
- Glucose provision: The 5% dextrose provides approximately 50 g/L of glucose, preventing hypoglycemia during periods when patients cannot take oral nutrition
- Metabolic support: Dextrose is rapidly metabolized and doesn't contribute to osmolarity calculations once infused
Research confirms this approach: a 2022 RCT demonstrated significantly higher rates of hyponatremia at 12 and 24 hours with D5 0.45% saline compared to D5 0.9% saline (P < 0.001) 2.
Prevention of Hypoglycemia
D5 solutions prevent hypoglycemia in patients who:
- Are NPO (nothing by mouth) for extended periods
- Have inadequate oral intake due to illness
- Are in postoperative states
Critical caveat: Despite average fasting times of 13 hours in elective surgery patients, hypoglycemia is rare. A 2006 study showed that 500 mL of D5 0.9% NaCl caused significant hyperglycemia (>10 mmol/L in 72% of patients) even in non-diabetics, suggesting routine use in elective surgery is unnecessary 3.
Specific Clinical Scenarios
Postoperative Nausea and Vomiting (PONV)
D5 or D10 solutions reduce PONV in high-risk patients when administered preoperatively. A 2022 RCT showed D10% significantly reduced PONV incidence compared to saline (12.5% vs 87.5%, P < 0.002) 4. Administer 100 mL/h starting one hour before anesthesia.
Hyperemesis Gravidarum
D5 0.9% saline shows equivalent efficacy to plain 0.9% saline for rehydration, with modest early benefit in nausea scores at 8-16 hours that dissipates by 24 hours 5. Either solution is appropriate.
Correction of Hyponatremia in CRRT
D5W (dextrose 5% in water) can be infused prefilter during continuous renal replacement therapy to prevent overcorrection of severe hyponatremia. This specialized use allows delivery of adequate effluent volumes while controlling sodium correction rates to <8 mEq/day, preventing osmotic demyelination syndrome 6.
When D5 is NOT Indicated
Hypoglycemia Treatment
D5 is inadequate for treating documented hypoglycemia. A 2024 RCT showed no difference in time to achieve GCS 15 between 10%, 25%, and 50% dextrose, but higher concentrations (25-50%) are standard for acute treatment 7. Use 25g of 50% dextrose or 1mg IM glucagon for symptomatic hypoglycemia.
Cardiac Arrest
Dextrose administration during CPR in patients with blood glucose <150 mg/dL showed no association with improved ROSC, survival, or neurological outcomes (aOR 1.44,95% CI 0.30-0.69) 8. Current guidelines appropriately omit dextrose from cardiac arrest protocols.
Elective Surgery in Non-Diabetics
Routine initiation with D5 solutions causes unnecessary hyperglycemia without preventing hypoglycemia 3. Start with non-dextrose crystalloids unless specific risk factors exist.
Practical Algorithm
For hospitalized children requiring maintenance IV fluids:
- Use D5 0.9% NaCl at standard maintenance rates
- Avoid hypotonic solutions (D5 0.45% NaCl, D5 0.2% NaCl)
- Monitor sodium at 12-24 hours if fluids continue
For adults:
- NPO >12-24 hours → Consider D5 0.9% NaCl
- High PONV risk → D10% preoperatively
- Elective surgery, normal intake → Avoid routine D5
- Documented hypoglycemia → Use D25% or D50%, not D5
Key pitfall: The historical practice of using hypotonic D5 solutions (D5 0.45% NaCl) based on 1950s calculations is dangerous and should be abandoned. These calculations were based on healthy children's energy expenditure, not acutely ill patients who have excess AVP release from pain, stress, and illness 1.